“CRCs are responsible for the majority of trial execution at any site, so investing in their professional development is crucial for long-term success of any research endeavor.”
Ask any study site: Sponsors are looking to lower costs at sites, while requiring higher quality and faster performance. To achieve this, many sponsors are expecting sites to deploy new technologies, but study sites face challenges in funding expensive platforms such as CTMS, eSource systems and eReg binders.
Funding for and access to clinical trials must be examined “though a lens of inclusion and communities of color,” advocate says.
Understanding the work of data monitoring and endpoint adjudication committees can open new career options for clinical trial practitioners, expert says.
“We need to understand what it will take for sites to be ready for DCTs.”